Celldex Therapeutics, Inc.
DE ˙ DB ˙ US15117B2025
€ 25,28 ↑0.78 (3.18%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:TCE2 / Celldex Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership217,335 shares
Latest Disclosed Value $ 6,893,866
Citigroup Inc ownership in TCE2 / Celldex Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 217,335 shares of Celldex Therapeutics, Inc. (DE:TCE2) valued at $5,563,776 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 14,922 shares of Celldex Therapeutics, Inc.. This represents a change in shares of 1,356.47% during the quarter. The current value of the position is $5,494,229 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (TCE2) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:TCE2 / Celldex Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 217,335 202,413 1,356.47 6,894 1,601.98 0.0015
2026-02-13 2025-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 14,922 -7,472 -33.37 405 -30.05 0.0002
2025-11-10 2025-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 22,394 -76,806 -77.43 579 -71.31 0.0003
2025-08-11 2025-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 99,200 -31,488 -24.09 2,019 -14.89 0.0010
2025-05-12 2025-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 130,688 11,329 9.49 2,372 -21.39 0.0012
2025-02-12 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 119,359 68,629 135.28 3,016 74.94 0.0018
2024-11-12 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 50,730 25,465 100.79 1,724 84.39 0.0010
2024-08-12 2024-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 25,265 -155,715 -86.04 935 -87.69 0.0006
2024-05-10 2024-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 180,980 118,639 190.31 7,596 207.24 0.0050
2024-02-09 2023-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 62,341 -7,014 -10.11 2,472 29.56 0.0017
2023-12-06 2023-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 69,355 -1,479 -2.09 1,909 -20.60 0.0014
2023-11-09 2023-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 69,355 -1,479 1,909 0.0006
2023-08-10 2023-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 70,834 -47,071 -39.92 2,403 -43.35 0.0016
2023-05-11 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 117,905 54,408 85.69 4,242 49.89 0.0030
2023-02-09 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 63,497 -125,915 -66.48 2,830 -46.84 0.0023
2022-11-10 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 189,412 33,735 21.67 5,324 26.85 0.0038
2022-08-10 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 155,677 92,158 145.09 4,197 93.95 0.0031
2022-05-12 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 63,519 -55,529 -46.64 2,164 -52.96 0.0013
2022-02-10 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 119,048 9,739 8.91 4,600 -22.06 0.0025
2021-11-10 2021-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 109,309 -10,945 -9.10 5,902 46.78 0.0035
2021-08-10 2021-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 120,254 -53,024 -30.60 4,021 12.63 0.0024
2021-05-13 2021-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 173,278 137,687 386.86 3,570 472.12 0.0023
2021-02-11 2020-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 35,591 35,591 624 0.0004
2019-11-08 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -200 -100.00 0 -100.00
2019-08-12 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 200 200 1 0.0000
2019-05-13 2019-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -31,234 -100.00 0 -100.00
2019-02-12 2018-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 31,234 -20,256 -39.34 6 -73.91 0.0000
2018-11-13 2018-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 51,490 -189,576 -78.64 23 -80.99 0.0000
2018-08-10 2018-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 241,066 162,669 207.49 121 -33.88 0.0001
2018-05-11 2018-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 78,397 48,995 166.64 183 120.48 0.0002
2018-02-12 2017-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 29,402 10,339 54.24 83 50.91 0.0001
2017-11-13 2017-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 19,063 1,042 5.78 55 25.00 0.0000
2017-08-11 2017-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 18,021 -98,894 -84.59 44 -89.57 0.0000
2017-05-12 2017-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 116,915 -308,063 -72.49 422 -71.94 0.0004
2017-02-10 2016-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 424,978 363,899 595.78 1,504 511.38 0.0014
2016-11-10 2016-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 61,079 14,214 30.33 246 19.42 0.0002
2016-08-12 2016-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 46,865 -49,260 -51.25 206 -43.25 0.0002
2016-05-13 2016-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 96,125 68,777 251.49 363 -15.19 0.0004
2016-02-12 2015-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 27,348 -22,131 -44.73 428 -18.01 0.0004
2015-11-13 2015-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 49,479 27,591 126.06 522 -5.43 0.0005
2015-08-13 2015-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 21,888 -5,913 -21.27 552 -28.77 0.0005
2015-05-14 2015-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 27,801 -12,835 -31.59 775 4.59 0.0007
2015-02-17 2014-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 40,636 31,783 359.01 741 550.00 0.0007
2014-11-14 2014-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 8,853 -1,165 -11.63 114 -30.06 0.0001
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 10,018 -37,204 -78.79 163 -80.46 0.0002
2014-05-15 2014-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 47,222 -26,705 -36.12 834 -53.38 0.0009
2014-02-14 2013-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 73,927 38,587 109.19 1,789 42.89 0.0016
2013-11-14 2013-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 35,340 32,449 1,122.41 1,252 2,621.74 0.0012
2013-08-14 2013-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,891 2,891 46 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-12 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-12 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 30,600 1,040 n/a n/a n/a
2023-05-11 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 10,000 0.00 446 58.36 n/a n/a n/a
2022-11-10 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 10,000 -91.67 281 -91.31 n/a n/a n/a
2022-08-10 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 120,000 -33.33 3,235 -47.24 n/a n/a n/a
2022-05-12 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 180,000 0.00 6,131 -11.85 n/a n/a n/a
2022-02-10 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 180,000 6,955 n/a n/a n/a
2020-02-12 2019-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-08 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 4,700 -6.34 10 -23.08 n/a n/a n/a
2019-08-12 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 5,018 16.21 13 n/a n/a n/a
2019-05-13 2019-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 4,318 0 n/a n/a n/a
2019-02-12 2018-12-31 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 n/a n/a n/a
2018-11-13 2018-09-30 13F CELLDEX THERAPEUTICS INC COM Call 700 -94.96 0 -100.00 n/a n/a n/a
2018-08-10 2018-06-30 13F CELLDEX THERAPEUTICS INC COM Call 13,900 -48.71 7 -88.89 n/a n/a n/a
2018-05-11 2018-03-31 13F CELLDEX THERAPEUTICS INC COM Call 27,100 -7.19 63 -24.10 n/a n/a n/a
2018-02-12 2017-12-31 13F CELLDEX THERAPEUTICS INC COM Call 29,200 -37.47 83 -38.06 n/a n/a n/a
2017-11-13 2017-09-30 13F CELLDEX THERAPEUTICS INC COM Call 46,700 131.19 134 168.00 n/a n/a n/a
2017-08-11 2017-06-30 13F CELLDEX THERAPEUTICS INC COM Call 20,200 83.64 50 25.00 n/a n/a n/a
2017-05-12 2017-03-31 13F CELLDEX THERAPEUTICS INC COM Call 11,000 -40.86 40 -39.39 n/a n/a n/a
2017-02-10 2016-12-31 13F CELLDEX THERAPEUTICS INC COM Call 18,600 39.85 66 22.22 n/a n/a n/a
2016-11-10 2016-09-30 13F CELLDEX THERAPEUTICS INC COM Call 13,300 -55.81 54 -59.09 n/a n/a n/a
2016-08-12 2016-06-30 13F CELLDEX THERAPEUTICS INC COM Call 30,100 -45.27 132 -36.54 n/a n/a n/a
2016-05-13 2016-03-31 13F CELLDEX THERAPEUTICS INC COM Call 55,000 26.73 208 -69.46 n/a n/a n/a
2016-02-12 2015-12-31 13F CELLDEX THERAPEUTICS INC COM Call 43,400 72.91 681 156.98 n/a n/a n/a
2015-11-13 2015-09-30 13F CELLDEX THERAPEUTICS INC COM Call 25,100 64.05 265 -31.35 n/a n/a n/a
2015-08-13 2015-06-30 13F CELLDEX THERAPEUTICS INC COM Call 15,300 386 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-11-10 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-10 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 10,000 270 n/a n/a n/a
2020-02-12 2019-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-08 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 1,000 -33.33 2 -50.00 n/a n/a n/a
2019-08-12 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 1,500 114.29 4 n/a n/a n/a
2019-05-13 2019-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 700 0 n/a n/a n/a
2019-02-12 2018-12-31 13F CELLDEX THERAPEUTICS INC COM Put 0 -100.00 0 n/a n/a n/a
2018-11-13 2018-09-30 13F CELLDEX THERAPEUTICS INC COM Put 100 -99.80 0 -100.00 n/a n/a n/a
2018-08-10 2018-06-30 13F CELLDEX THERAPEUTICS INC COM Put 50,900 34.30 26 -70.45 n/a n/a n/a
2018-05-11 2018-03-31 13F CELLDEX THERAPEUTICS INC COM Put 37,900 742.22 88 576.92 n/a n/a n/a
2018-02-12 2017-12-31 13F CELLDEX THERAPEUTICS INC COM Put 4,500 -81.25 13 -81.16 n/a n/a n/a
2017-11-13 2017-09-30 13F CELLDEX THERAPEUTICS INC COM Put 24,000 -10.11 69 4.55 n/a n/a n/a
2017-08-11 2017-06-30 13F CELLDEX THERAPEUTICS INC COM Put 26,700 -43.31 66 -61.18 n/a n/a n/a
2017-05-12 2017-03-31 13F CELLDEX THERAPEUTICS INC COM Put 47,100 187.20 170 193.10 n/a n/a n/a
2017-02-10 2016-12-31 13F CELLDEX THERAPEUTICS INC COM Put 16,400 0.61 58 -12.12 n/a n/a n/a
2016-11-10 2016-09-30 13F CELLDEX THERAPEUTICS INC COM Put 16,300 -57.66 66 -60.95 n/a n/a n/a
2016-08-12 2016-06-30 13F CELLDEX THERAPEUTICS INC COM Put 38,500 8.15 169 25.19 n/a n/a n/a
2016-05-13 2016-03-31 13F CELLDEX THERAPEUTICS INC COM Put 35,600 493.33 135 43.62 n/a n/a n/a
2016-02-12 2015-12-31 13F CELLDEX THERAPEUTICS INC COM Put 6,000 -25.93 94 10.59 n/a n/a n/a
2015-11-13 2015-09-30 13F CELLDEX THERAPEUTICS INC COM Put 8,100 102.50 85 -15.84 n/a n/a n/a
2015-08-13 2015-06-30 13F CELLDEX THERAPEUTICS INC COM Put 4,000 700.00 101 621.43 n/a n/a n/a
2015-05-14 2015-03-31 13F CELLDEX THERAPEUTICS INC COM Put 500 14 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.